ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,269, issued on Dec. 2, was assigned to Aconcagua Bio Inc. (South San Francisco, Calif.).

"Compounds and compositions for treating conditions associated with calcitonin receptor and/or amylin receptor activity" was invented by Hui Lei (Shanghai), Cui Li (Shanghai), Chunliang Lu (Shanghai), Ding Xue (Shanghai), Haizhen Zhang (Shanghai), Zhuming Zhang (Shanghai), Jian Liu (New York), Zhe Nie (New York), Anatoly Ruvinsky (New York), Eric Therrien (New York) and Evelyne Houang (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides compounds for modulating calcitonin receptor and/or amylin receptor activity, as well as pha...